In this study, we found that the serum VEGF level during radiotherapy is the independent factor for predicting short-term efficacy in ESCC patients: low serum VEGF level during radiotherapy indicates good short-term efficacy. This evidence concerns the gene VEGFA and esophageal squamous cell carcinoma.